WASHINGTON (MedPage Today) — Two days after president Barak Obama delivered his first State of the Union address, he told House Republicans that GOP rhetoric is ruining the chance for bi-partisanship on healthcare reform.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A century ago, Abraham Flexner’s pivotal report redefined medical education and heralded the growth of academic medical centers, but increasing medical specialization was an unintended consequence and threatens patient care, according to a paper published in an anniversary issue of Academic Medicine.
No Comments »
Filed under: General Health News
Keryx Biopharmaceuticals, Inc…
No Comments »
Filed under: Pharmacy News
The Bienville Democrat in Arcadia, LA recently reported that America’s pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines…
No Comments »
Filed under: Pharmacy News
The transfer into clinical development of a patient-specific vaccine represents a milestone for Bayer Innovation GmbH. Following approval of the Phase I study by the FDA (Food & Drug Administration) in the United States, the vaccine is now being tested in human subjects. This is the first time that proteins obtained from tobacco plants using [...]
No Comments »
Filed under: Pharmacy News
Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes Novo Nordisk announced today that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults…
No Comments »
Filed under: Pharmacy News
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program…
No Comments »
Filed under: Pharmacy News
GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB® (lapatinib) as a first-line, all-oral treatment for women with metastatic breast cancer…
No Comments »
Filed under: Pharmacy News
The New England Journal of Medicine (NEJM) published the first study demonstrating that Rotarix™, GlaxoSmithKline’s rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2% of these infants. The study also showed that Rotarix…
No Comments »
Filed under: Pharmacy News
Senomyx is using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries. The Company’s flavor programs are focused on creating new ingredients that enhance sweet, savory, salty, and cooling tastes, as well as ingredients that reduce bitter taste. These new flavor ingredients include S6973, a unique sucrose [...]
No Comments »
Filed under: Pharmacy News
